Bazo-Alvarez Juan Carlos, Quispe Renato, Peralta Frank, Poterico Julio A, Valle Giancarlo A, Burroughs Melissa, Pillay Timesh, Gilman Robert H, Checkley William, Malaga Germán, Smeeth Liam, Bernabé-Ortiz Antonio, Miranda J Jaime
From the *CRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru; †Santa Cruz de Ratacocha Primary Healthcare Centre, Social Service in Rural Setting, Ministry of Health, Huanuco, Peru; ‡Division of Cardiology, Department of Medicine, §Duke Clinical Research Institute, ¶Duke Global Health Institute, Duke University, Durham, NC; ‖School of Medicine, University College London, London, UK; **Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; ††Asociación Benéfica PRISMA, Lima, Peru; ‡‡Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, MD; §§Department of Medicine, School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru; and ¶¶Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Crit Pathw Cardiol. 2015 Jun;14(2):74-80. doi: 10.1097/HPC.0000000000000045.
It is unclear how well currently available risk scores predict cardiovascular disease (CVD) risk in low-income and middle-income countries. We aim to compare the American College of Cardiology/American Heart Association (ACC/AHA) Pooled Cohort risk equations (ACC/AHA model) with 6 other CVD risk tools to assess the concordance of predicted CVD risk in a random sample from 5 geographically diverse Peruvian populations. We used data from 2 Peruvian, age and sex-matched, population-based studies across 5 geographical sites. The ACC/AHA model were compared with 6 other CVD risk prediction tools: laboratory Framingham risk score for CVD, non-laboratory Framingham risk score for CVD, Reynolds risk score, systematic coronary risk evaluation, World Health Organization risk charts, and the Lancet chronic diseases risk charts. Main outcome was in agreement with predicted CVD risk using Lin's concordance correlation coefficient. Two thousand one hundred and eighty-three subjects, mean age 54.3 (SD ± 5.6) years, were included in the analysis. Overall, we found poor agreement between different scores when compared with ACC/AHA model. When each of the risk scores was used with cut-offs specified in guidelines, ACC/AHA model depicted the highest proportion of people at high CVD risk predicted at 10 years, with a prevalence of 29.0% (95% confidence interval, 26.9-31.0%), whereas prevalence with World Health Organization risk charts was 0.6% (95% confidence interval, 0.2-8.6%). In conclusion, poor concordance between current CVD risk scores demonstrates the uncertainty of choosing any of them for public health and clinical interventions in Latin American populations. There is a need to improve the evidence base of risk scores for CVD in low-income and middle-income countries.
目前尚不清楚现有风险评分在低收入和中等收入国家预测心血管疾病(CVD)风险的效果如何。我们旨在将美国心脏病学会/美国心脏协会(ACC/AHA)汇总队列风险方程(ACC/AHA模型)与其他6种CVD风险工具进行比较,以评估来自秘鲁5个地理区域不同人群的随机样本中预测的CVD风险的一致性。我们使用了来自秘鲁2项基于人群的年龄和性别匹配研究的数据,涵盖5个地理地点。将ACC/AHA模型与其他6种CVD风险预测工具进行比较:实验室版心血管疾病弗雷明汉风险评分、非实验室版心血管疾病弗雷明汉风险评分、雷诺兹风险评分、系统性冠状动脉风险评估、世界卫生组织风险图表以及《柳叶刀》慢性病风险图表。主要结局是使用林氏一致性相关系数与预测的CVD风险达成一致。分析纳入了2183名受试者,平均年龄54.3(标准差±5.6)岁。总体而言,与ACC/AHA模型相比,我们发现不同评分之间的一致性较差。当按照指南规定的临界值使用每种风险评分时,ACC/AHA模型显示预测10年心血管疾病高风险人群的比例最高,患病率为29.0%(95%置信区间,26.9 - 31.0%),而世界卫生组织风险图表的患病率为0.6%(95%置信区间,0.2 - 8.6%)。总之,当前心血管疾病风险评分之间的一致性较差,这表明在拉丁美洲人群中为公共卫生和临床干预选择其中任何一种评分都存在不确定性。有必要改善低收入和中等收入国家心血管疾病风险评分的证据基础。